Breast Cancer
Showing NaN - NaN of 157
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)
Recruiting
- Metastatic Breast Cancer
- +2 more
- Samuraciclib
- Elacestrant Dihydrochloride
-
Orange City, Florida
- +27 more
Jul 19, 2023
Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)
Completed
- Breast Cancer
- Stage IV Breast Cancer
- palliative surgery
- +3 more
-
Mobile, Alabama
- +376 more
Jan 6, 2023
Breast Cancer Trial in United States (ARV-471, ARV-471 in combination with palbociclib (IBRANCEĀ®))
Recruiting
- Breast Cancer
- ARV-471
- ARV-471 in combination with palbociclib (IBRANCEĀ®)
-
Palo Alto, California
- +16 more
Jan 30, 2023
Quantitative MRI Assessment of Breast Cancer Therapy Response
Recruiting
- Breast Cancer
- Diffusion Weighted Imaging
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
-
Iowa City, Iowa
- +2 more
Jan 19, 2023
Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)
Active, not recruiting
- Breast Cancer
- Positron emission tomography (PET)
- +2 more
-
Birmingham, Alabama
- +9 more
Jan 20, 2023
HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)
Completed
- HER2-positive Breast Cancer
- +5 more
-
Tucson, Arizona
- +15 more
Dec 22, 2022
Breast Cancer, Pain Trial in United States (acupuncture therapy, sham acupuncture)
Completed
- Breast Cancer
- Pain
- acupuncture therapy
- sham acupuncture
-
Antioch, California
- +46 more
Dec 5, 2022
Breast Cancer Trial in Greece, Israel, United States (MammaPrint, BluePrint, and Full-Genome Testing)
Recruiting
- Breast Cancer
- MammaPrint, BluePrint, and Full-Genome Testing
-
Birmingham, Alabama
- +117 more
Dec 1, 2022
Breast Cancer Trial in Worldwide (Olaparib, Placebo)
Breast Cancer Trial in United States (Photon, Proton)
Recruiting
- Breast Cancer
- Photon
- Proton
-
Birmingham, Alabama
- +40 more
Nov 18, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Cancer Trial in Worldwide (biological, drug, other, procedure)
Active, not recruiting
- Breast Cancer
- nivolumab
- +6 more
-
Mobile, Alabama
- +255 more
Jul 21, 2022
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- therapeutic conventional surgery
- whole breast irradiation
-
Hot Springs, Arkansas
- +349 more
Jun 16, 2022
Breast Cancer Trial in Seattle (Automated message, Opt-out scheduling)
Not yet recruiting
- Breast Cancer
- Automated message
- Opt-out scheduling
-
Seattle, WashingtonVA Puget Sound Health Care System
Apr 5, 2022
Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)
Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples
Enrolling by invitation
- Breast Cancer
- +4 more
-
Seattle, WashingtonGBC
Mar 14, 2022
Breast Cancer Trial in Worldwide (trastuzumab, docetaxel, lapatinib ditosylate)
Active, not recruiting
- Breast Cancer
- trastuzumab
- +3 more
-
Anchorage, Alaska
- +257 more
Feb 28, 2022